Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Case Report
Mycosis fungoides in an 11-year-old child
- EHA 2025
Progress in multiple myeloma
- Interstitial lung diseases
Artificial intelligence improves ILD diagnosis
- Management of patients after alloHCST
ERS/EBMT guideline recommendations on pulmonary cGvHD
- Pyoderma gangraenosum
New study data confirm the validity of the PARACELSUS score
- Progressive multiple sclerosis
New horizons: from BTK inhibitors to remyelination
- Cutaneous and especially facial metastases
Rare manifestations of esophageal carcinoma
- Rare pulmonary syndromes